We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$617M
AUM Growth
-$15.9M
Cap. Flow
+$2.55M
Cap. Flow %
0.41%
Top 10 Hldgs %
29.29%
Holding
317
New
11
Increased
93
Reduced
96
Closed
19

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$5.45M
2
GCO icon
Genesco
GCO
+$1.35M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.1M
4
CMG icon
Chipotle Mexican Grill
CMG
+$762K
5
IBB icon
iShares Biotechnology ETF
IBB
+$665K

Top Sells

Rank Stock Value
1
SNDK
SANDISK CORP
SNDK
+$3.86M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.12M
3
KSU
Kansas City Southern
KSU
+$846K
4
MET icon
MetLife
MET
+$568K
5
BHC icon
Bausch Health
BHC
+$407K

Sector Composition

Rank Sector Weight
1 Healthcare 23.26%
2 Industrials 15.25%
3 Consumer Staples 12.09%
4 Technology 8.47%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
26
Bank of America
BAC
$436B
$6.19M 1%
457,998
+34,150
+8% +$461K
MMP
27
DELISTED
Magellan Midstream Partners, L.P.
MMP
$5.83M 0.95%
84,811
-4,993
-6% -$326K
XOM icon
28
ExxonMobil
XOM
$642B
$5.81M 0.94%
69,514
-1,227
-2% -$98.3K
PFE icon
29
Pfizer
PFE
$141B
$5.58M 0.9%
198,241
+3,410
+2% +$97.4K
GILD icon
30
Gilead Sciences
GILD
$162B
$5.5M 0.89%
59,915
+950
+2% +$85.7K
C icon
31
Citigroup
C
$223B
$5.3M 0.86%
127,005
+4,616
+4% +$193K
SPG icon
32
Simon Property Group
SPG
$75.1B
$5.02M 0.81%
24,151
– –
TMO icon
33
Thermo Fisher Scientific
TMO
$208B
$4.93M 0.8%
34,812
+20
+0.1% +$2.68K
BA icon
34
Boeing
BA
$167B
$4.91M 0.8%
38,674
-284
-0.7% -$35.2K
CSCO icon
35
Cisco
CSCO
$452B
$4.9M 0.79%
172,085
+5,750
+3% +$148K
T icon
36
AT&T
T
$167B
$4.41M 0.71%
148,995
-1,382
-0.9% -$38.3K
IBM icon
37
IBM
IBM
$204B
$4.35M 0.7%
30,030
-732
-2% -$93.5K
ACAD icon
38
Acadia Pharmaceuticals
ACAD
$4.35B
$4.34M 0.7%
155,190
+50,540
+48% +$1.1M
EL icon
39
Estee Lauder
EL
$30.1B
$4.27M 0.69%
45,234
– –
MRK icon
40
Merck
MRK
$323B
$4.22M 0.68%
83,520
+714
+0.9% +$35K
EPD icon
41
Enterprise Products Partners
EPD
$82.5B
$4.17M 0.68%
169,163
-5,474
-3% -$127K
RTX icon
42
RTX Corp
RTX
$294B
$4.02M 0.65%
63,859
+4,416
+7% +$256K
CVS icon
43
CVS Health
CVS
$137B
$4M 0.65%
38,524
+145
+0.4% +$14.1K
MO icon
44
Altria Group
MO
$122B
$3.94M 0.64%
62,947
+143
+0.2% +$8.65K
CVX icon
45
Chevron
CVX
$378B
$3.62M 0.59%
37,937
+230
+0.6% +$20.1K
QQQ icon
46
Invesco QQQ Trust
QQQ
$449B
$3.46M 0.56%
31,729
+1,461
+5% +$152K
EOG icon
47
EOG Resources
EOG
$74.7B
$3.41M 0.55%
46,965
+3,115
+7% +$215K
FDX icon
48
FedEx
FDX
$73.5B
$3.31M 0.54%
20,334
– –
KSU
49
DELISTED
Kansas City Southern
KSU
$3.21M 0.52%
37,530
-10,850
-22% -$846K
WFC icon
50
Wells Fargo
WFC
$264B
$3.16M 0.51%
65,290
+800
+1% +$39.2K
1
2
3 4 5

Similar funds

KRC
Kingdom Ridge Capital White Plains, New York $750M AUM 34.23% 1-Year Est. Return
GS
GAM Systematic Cambridge, United Kingdom $696M AUM 28.4% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
B
BancorpSouth Tupelo, Mississippi $1.01B AUM 4.88% 1-Year Est. Return
JPCCM
J&P (China) Capital Management Hong Kong, China $586M AUM 82.64% 1-Year Est. Return
NBC
Neuberger Berman Canada Toronto, Ontario, Canada $542M AUM 14.17% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
SD
Sumway Development Shanghai, China $427M AUM 43.82% 1-Year Est. Return

Gerald L. Ray & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Gerald L. Ray & Associates held 317 positions worth $617M, down 2.5% from $633M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gerald L. Ray & Associates's Q1 2016 filing shows 11 new, 93 increased, 96 reduced and 19 closed positions. Its largest new stake was Genesco: 20,861 shares worth $1.51M. The largest sale was SANDISK CORP, an estimated $3.86M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q1 2016 buy was Genesco: 20,861 shares worth $1.51M.
  • Gerald L. Ray & Associates added most to Lowe's Companies in Q1 2016, an estimated $5.45M increase.
  • Gerald L. Ray & Associates's biggest Q1 2016 reduction was SANDISK CORP, cutting an estimated $3.86M.
  • Gerald L. Ray & Associates fully exited Bausch Health in Q1 2016, selling an estimated $407K.
  • Gerald L. Ray & Associates's ten largest holdings make up 29% of its $617M portfolio in Q1 2016.
  • Gerald L. Ray & Associates opened 11 new positions and closed 19 in Q1 2016.
  • Gerald L. Ray & Associates's portfolio value fell 2.5% quarter-over-quarter to $617M.

Based on Gerald L. Ray & Associates's 13F filing for Q1 2016, filed 5 May 2016.